D'ABUNDO, Lucilla
 Distribuzione geografica
Continente #
NA - Nord America 2.844
EU - Europa 1.626
AS - Asia 1.340
SA - Sud America 184
AF - Africa 34
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.032
Nazione #
US - Stati Uniti d'America 2.759
SG - Singapore 491
DE - Germania 475
CN - Cina 319
PL - Polonia 300
FI - Finlandia 265
IT - Italia 265
VN - Vietnam 168
BR - Brasile 133
HK - Hong Kong 94
GB - Regno Unito 82
UA - Ucraina 63
BD - Bangladesh 62
CA - Canada 47
TR - Turchia 44
ID - Indonesia 39
FR - Francia 38
SE - Svezia 37
JP - Giappone 32
IN - India 27
MX - Messico 26
AR - Argentina 24
RU - Federazione Russa 23
ES - Italia 16
NL - Olanda 14
CZ - Repubblica Ceca 11
IQ - Iraq 11
ZA - Sudafrica 11
LT - Lituania 9
AT - Austria 7
CO - Colombia 7
UZ - Uzbekistan 6
EG - Egitto 5
PK - Pakistan 5
SA - Arabia Saudita 5
VE - Venezuela 5
BO - Bolivia 4
CL - Cile 4
KR - Corea 4
MA - Marocco 4
MY - Malesia 4
AU - Australia 3
HR - Croazia 3
JM - Giamaica 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BE - Belgio 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.032
Città #
Munich 409
Ashburn 406
Singapore 301
Warsaw 297
Fairfield 247
San Jose 244
Helsinki 197
Woodbridge 174
Houston 135
Beijing 124
Seattle 119
Chandler 110
Wilmington 99
Cambridge 95
Santa Clara 95
Hong Kong 89
Ann Arbor 77
Ferrara 74
Jacksonville 71
New York 70
Los Angeles 57
Ho Chi Minh City 50
Dallas 46
Jakarta 34
Tokyo 32
Hanoi 31
Milan 31
Nanjing 26
Shanghai 26
London 25
Turku 24
Orem 22
Lauterbourg 21
Atlanta 20
Izmir 20
Jyväskylä 20
Montreal 20
Princeton 19
São Paulo 19
Chicago 18
Council Bluffs 18
Rome 14
San Diego 14
Turin 14
Denver 13
Mexico City 13
Boardman 12
Phoenix 12
Nanchang 11
Bologna 10
Dong Ket 10
Nuremberg 10
Manchester 9
Mountain View 9
San Francisco 9
Stockholm 9
Toronto 9
Chennai 8
Johannesburg 8
Shenyang 8
Boston 7
Da Nang 7
Falls Church 7
Redwood City 7
Addison 6
Bremen 6
Brno 6
Buffalo 6
Haiphong 6
Hefei 6
Poplar 6
Tashkent 6
Baghdad 5
Dearborn 5
Guangzhou 5
Hebei 5
Naples 5
Pavia 5
Salt Lake City 5
Tianjin 5
Vancouver 5
Vienna 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Brooklyn 4
Cagliari 4
Changsha 4
Guarulhos 4
Honolulu 4
Kunming 4
Lancaster 4
Moscow 4
New Delhi 4
Ningbo 4
Ninh Bình 4
Quảng Ngãi 4
Riyadh 4
The Dalles 4
Washington 4
Totale 4.413
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 403
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 371
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 303
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 301
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 298
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 286
Studi pre-clinici per lo sviluppo di approcci terapeutici basati sui microRNA in un modello di Leucemia Linfatica Cronica 278
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 267
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 266
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 254
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 243
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 237
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 237
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 236
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 226
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 202
Mutated beta-catenin evades a microRNA-dependent regulatory loop 187
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 181
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 174
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 173
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 169
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells 164
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 136
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 128
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells 104
null 89
P3.12.20 VAF of EGFR Mutations in Relation to Early Tumor Shrinkage or Deepness of Response During Osimertinib in NSCLC Patients 76
null 63
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 57
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 16
Totale 6.125
Categoria #
all - tutte 22.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022222 11 20 23 3 10 13 10 15 6 18 25 68
2022/2023246 19 19 12 29 44 33 17 17 30 3 13 10
2023/2024238 13 21 9 5 17 48 12 48 1 9 4 51
2024/20251.393 20 17 59 37 90 186 217 144 279 91 111 142
2025/20262.282 235 52 136 276 341 159 347 124 217 230 156 9
Totale 6.125